Speaker Details

Iltefat H. Hamzavi, MD, FAAD

Iltefat H. Hamzavi, MD, FAAD

SESSIONS

F029 Dietary Triggers and Modifications of Common Dermatologic Conditions: An Evidence Based Approach
Mar 8, 2024 • 3:30 PM - 5:30 PM • Room 5B
S030 Vitiligo
Mar 9, 2024 • 9:00 AM - 12:00 PM • Room 6C
F046 HS Surgery from Start to Finish: Planning, Procedures, and Post-op Care
Mar 9, 2024 • 9:00 AM - 11:00 AM • Room 1B
U072 Updates on Using and Understanding Light in Dermatology
Mar 10, 2024 • 4:30 PM - 5:30 PM • Room 4
S060 Skin of Color
Mar 11, 2024 • 1:00 PM - 4:00 PM • Room 6B

DISCLOSURES

AbbVie – Advisory Board(Fees); Almirall – Consultant (1099 relationship)(Fees); Avita – Investigator(Grants/Research Funding); Beiersdorf, Inc. – Advisory Board(Fees); Boehringer Ingelheim – Consultant(Fees); Clinuvel – Investigator(Fees); Galderma Laboratories, L.P. – Investigator(Fees); Global Vitiligo Foundation – Board of Directors(No Compensation Received); Hidradenitis Suppurativa Foundation – Board of Directors(No Compensation Received); Incyte Corporation – Investigator(Grants/Research Funding); Janssen Biotech – Investigator(Grants/Research Funding); L'Oreal USA Inc. – Investigator(Grants/Research Funding); Lenicura – Investigator(Equipment); MyDerm Portal, Inc – Stockholder(Stock); Novartis – Consultant(Fees); Pfizer Inc. – Investigator(Fees); Sonoma Biotherapeutics – Investigator(Grants/Research Funding); UCB – Consultant(Fees); Union Therapeutics – Consultant(Fees); Vimela – Consultant (1099 relationship)(Fees);